BioMimetic Therapeutics, Inc. news

   Watch this stock
Showing stories 1 - 10 of about 71   

Articles published

BMTI 0.0000
price chart
Wright Medical Group, Inc. and BioMimetic Therapeutics, Inc. Enter into ...
BUSINESS WIRE)--Wright Medical Group, Inc. (NASDAQ: WMGI) and BioMimetic Therapeutics, Inc. (NASDAQ: BMTI) announced today that they have entered into a definitive agreement for a business combination of Wright and BioMimetic, both publicly ...
BioMimetic Therapeutics agrees to $380M sale to Wright Medical  L.A. Biz
Biomimetic Therapeutics (BMTI) Jumps After Business Combination With Wright ...  iStockAnalyst
Related articles »  
Wright Medical Group, Inc. Completes Acquisition of BioMimetic Therapeutics, Inc.
ARLINGTON, Tenn.--(BUSINESS WIRE)--Wright Medical Group, Inc. (NASDAQ: WMGI) today announced that it has completed its acquisition of BioMimetic Therapeutics, Inc. The transaction combines BioMimetic's breakthrough biologics platform and pipeline ...
BioMimetic Therapeutics, Inc. to Introduce Augmatrix� Biocomposite Bone Graft ...
FRANKLIN, Tenn.--(BUSINESS WIRE)--BioMimetic Therapeutics, Inc. (NASDAQ: BMTI) today announced it will introduce Augmatrix� Biocomposite Bone Graft, a new bone graft substitute product line, to surgeons and distributors at its exhibit booth during the ...
Related articles »  
Keeping The Faith On BioMimetic Therapeutics
It hasn't been easy to stay bullish on BioMimetic Therapeutics (BMTI), as the stock has stagnated while the company worked to resubmit its PMA for its Augment bone graft product. What's more, news about under-reported side-effects and over-promised for ...
BioMimetic Therapeutics Submits Augment� Bone Graft PMA Amendment to FDA  Business Wire (press release)
BioMimetic Therapeutics Submits Augment Bone Graft PMA Amendment to FDA  RTT News
Related articles »  
Wright Medical completes acquisition of BioMimetic Therapeutics
Wright Medical Group Inc. (Nasdaq: WMGI) has finalized its $380 million purchase of Nashville-based BioMimetic Therapeutics Inc. under terms that included an up-front payment of about $190 million in cash and stock. Wright Medical, which is ...
Wright Medical Group acquires BioMimetic Therapeutics
Wright Closes Up-To-$380M BioMimetic Purchase  Genetic Engineering News
Related articles »  
BioMimetic Therapeutics Receives Augment� Bone Graft PMA Response Letter ...
FRANKLIN, Tenn.--(BUSINESS WIRE)--BioMimetic Therapeutics, Inc. (NASDAQ: BMTI) announced today that it received a comprehensive post-panel response letter from the FDA related to the Company's Pre-Market Approval (PMA) application for ...
BioMimetic Therapeutics: The FDA Gives A Smudged Map For The Minefields  Seeking Alpha
Related articles »  
BioMimetic Therapeutics, Inc. Receives Approval to Commercialize Augment ...
BUSINESS WIRE)--BioMimetic Therapeutics, Inc. (NASDAQ: BMTI) today announced that the Therapeutic Goods Administration (TGA) has approved the Company's medical device application for Augment� Bone Graft clearing the way for commercialization ...
Related articles »  
BioMimetic Looks Like Serious Augmentation For Wright Medical
As a BioMimetic Therapeutics (NASDAQ:BMTI) shareholder, I have long regarded a buy-out as the overwhelmingly logical end game for the company. While I would have initially preferred to see one of the ortho giants like Johnson & Johnson (NYSE:JNJ), ...
Related articles »  
Stocks to Watch: BioMimetic Therapeutics, Diamond Foods, Lowe's
Wright Medical Group Inc.WMGI -2.40% (WMGI) agreed to acquire fellow medical-device maker BioMimetic Therapeutics Inc. for about $190 million in cash and stock as it looks to expand its extremities business.
Related articles »  
Executive Q&A: BioMimetic founder Samuel Lynch promotes life sciences in TN
One example is Lynch's company, BioMimetic Therapeutics Inc., which was purchased by Memphis-based Wright Medical Group Inc. last year.
Related articles »